SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-233424
Filing Date
2013-05-23
Accepted
2013-05-23 16:04:28
Documents
4
Period of Report
2013-06-27
Effectiveness Date
2013-05-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d503608ddef14a.htm DEF 14A 657498
2 GRAPHIC g503608g88h87.jpg GRAPHIC 8007
3 GRAPHIC g503608pc_pg1.jpg GRAPHIC 144270
4 GRAPHIC g503608pc_pg2.jpg GRAPHIC 128280
  Complete submission text file 0001193125-13-233424.txt   1045550
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19825 | Film No.: 13868345
SIC: 2834 Pharmaceutical Preparations